Children have not been spared from COVID-19. Review research into multi-system inflammatory syndrome in children (MIS-C), including timing, symptomatology, and complication potential. Read more.
Foreign national business has been growing in the US for several years. High-net-worth individuals want to diversify their portfolios into US investments which include life insurance, yet understanding the foreign national segment can be challenging. […]
Tetrahydrocannabinol (THC) use has increased substantially in the last decade. Curious what the science says about health impacts and mortality implications, and how use and age patterns can guide underwriting decisions? Read more.
There is no guide for a pandemic, but insurers can learn lessons in compassion, communication, and common purpose. Gain views from three leaders in OTR.
Well rounded, highly educated, younger and growing in numbers. The profession of Life Underwriter is changing. Curious? Read more in OTR.
In the ideal world, a life underwriter would have all the information necessary to assess risk. But in reality, such data can be elusive. Get pragmatic best practices in OTR.
As diabetes reaches record levels, could the standard glycated hemoglobin A1c test to detect diabetes also serve as a blood biomarker for mortality? Rethink the purpose of this popular test.
Some are calling it the new addiction of the 21st century. Learn more about the physical and psychological implications of smartphone addiction and how it could impact life and disability insurance applications in OTR.
The face of stroke is younger than ever before. Out of every six strokes occurs in young adults, with stroke hospitalization rates on the rise among patients aged 18-64. Explore the risk factors in OTR.
Is it past time to update underwriting guidelines on hypertension? As scientific understanding advances, read a compelling case for new criteria for the diagnosis and treatment of high blood pressure. Don’t have the latest issue? […]